Frances Andtbacka is currently the Global Marketing Oncology Director for the Head & Neck Cancers Portfolio Disease Strategy Lead at Merck, where they focus on R/M HNSCC and lead the launch for LA HNSCC. They have over 15 years of extensive experience in the pharmaceutical industry, specifically in hematology and oncology, with a strong background in conditions such as Multiple Myeloma and melanoma. Prior to their current role, Frances held various positions at Novartis and Bayer Pharmaceuticals, including Senior Hematology Sales Specialist and Global Marketing Oncology roles. Frances earned a BA in Psychology and Mathematics from Hunter College and is pursuing Pre-Medical studies at SUNY New Paltz.
This person is not in any teams
This person is not in any offices